<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJCD</journal-id><journal-title-group><journal-title>World Journal of Cardiovascular Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-5329</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/wjcd.2024.144017</article-id><article-id pub-id-type="publisher-id">WJCD-132467</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Interest of Cardiac Rehabilitation in Patients with Heart Disease in a Cardiology Department in Senegal
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Awa</surname><given-names>Ba-Diop</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdou</surname><given-names>Khadir Sow</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rim</surname><given-names>Mohamed Khaled</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mor</surname><given-names>Diaw</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mame</surname><given-names>Saloum Coly</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fulgence</surname><given-names>Abdou Faye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Amadou</surname><given-names>Ndiad&amp;#233;</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bamba</surname><given-names>Gaye</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoulaye</surname><given-names>Ba</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoulaye</surname><given-names>Samb</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Laboratory of Physiology and Functional Explorations, Department of Medicine, Alioune Diop University of Bambey, Bambey, Senegal</addr-line></aff><aff id="aff4"><addr-line>Laboratory of Physiology and Functional Explorations, UFR Sant&amp;amp;#233;, UAS of Thi&amp;amp;#232;s, Thi&amp;amp;#232;s, Senegal</addr-line></aff><aff id="aff3"><addr-line>IRL3189 Environment, Health, Societies, CNRS-UCAD, Dakar, Senegal</addr-line></aff><aff id="aff5"><addr-line>The African Research Network Noncommunicable Diseases, Dakar, Senegal</addr-line></aff><aff id="aff2"><addr-line>Laboratory of Physiology and Functional Explorations, FMPOS UCAD, Dakar, Senegal</addr-line></aff><pub-date pub-type="epub"><day>12</day><month>04</month><year>2024</year></pub-date><volume>14</volume><issue>04</issue><fpage>217</fpage><lpage>227</lpage><history><date date-type="received"><day>19,</day>	<month>January</month>	<year>2024</year></date><date date-type="rev-recd"><day>13,</day>	<month>April</month>	<year>2024</year>	</date><date date-type="accepted"><day>16,</day>	<month>April</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Cardiac rehabilitation helps improve the prognosis and quality of life for patients with heart disease. To show its interest in the African context, in the management of heart disease, a prospective study was carried out. Its objective was to evaluate the effects of physical rehabilitation on cardiac function. &lt;b&gt;Methods:&lt;/b&gt; Patients were evaluated at the beginning and at the end of cardiovascular rehabilitation by cardiovascular, biological, and echocardiographic parameters including the size of the heart chambers, the kinetics of the walls, and the systolic function of the ventricles. &lt;b&gt;Results:&lt;/b&gt; The study involved 12 patients, 67% of whom were men. After cardiac rehabilitation, the mean hemodynamic constants had not been significantly modified. However, a significant decrease in Total-Cholesterol, LDL-Cholesterol and triglyceride levels was noted. Mean fasting blood sugar decreased from 1.25 &amp;#177; 0.48 g/L to 0.92 &amp;#177; 0.18 g/L and glycated hemoglobin from 7.72% &amp;#177; 0.01% to 6.45% &amp;#177; 0.008%. The echocardiographic parameters studied showed an improvement in the dilation of the heart chambers in 8.33% of the patients, the normalization of the ejection fraction of the left ventricle in 16% patients, the improvement of the kinetic disorders in 16% of patients and recovery of right ventricular systolic function in all patients. &lt;b&gt;Conclusion:&lt;/b&gt; Cardiac rehabilitation as a secondary preventive measure for cardiovascular disease has contributed significantly to improving the clinico-biological parameters of the disease.
 
</p></abstract><kwd-group><kwd>Cardiac Rehabilitation</kwd><kwd> Heart Disease</kwd><kwd> Cardiovascular Disease</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Cardiovascular diseases (CVD) are a major factor of morbidity and mortality worldwide, accounting for about 50% of deaths from non-communicable diseases (NCD) [<xref ref-type="bibr" rid="scirp.132467-ref1">1</xref>] , of which 80% occur in low- and middle-income countries. The burden of NCD and CVD is increasing in sub-Saharan Africa (SSA) [<xref ref-type="bibr" rid="scirp.132467-ref2">2</xref>] . Heart failure (HF) is a common terminal complication of these CVD. In SSA, heart failure mainly affects young economically active adults, resulting in impaired quality of life and loss of productivity for patients, their families and society in general [<xref ref-type="bibr" rid="scirp.132467-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref4">4</xref>] . In Senegal, the prevalence of heart failure was estimated at 14.28% in 2019 [<xref ref-type="bibr" rid="scirp.132467-ref5">5</xref>] . However, many advances have been made in their management, including cardiac rehabilitation (CR). CR is defined as “the sum of activities required to influence favorably the underlying cause of the disease, as well as to provide the best possible physical, mental and social conditions, so that the patients may, by their own efforts, preserve or resume as normal a place as possible in the community” [<xref ref-type="bibr" rid="scirp.132467-ref6">6</xref>] . CR has helped to improve the functional prognosis and quality of life of patients with these heart diseases in high-income countries. It could represent an important approach to mitigate the epidemic of CVD in low-resource settings such as SSA [<xref ref-type="bibr" rid="scirp.132467-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref8">8</xref>] . Although there is substantial evidence of the benefits of exercise-based rehabilitation in the prevention and management of cardiovascular diseases, it is very underused in SSA. It is often under-prescribed and has low adherence rates. The commonly cited barriers to its use and the drivers of early dropout of participants are poor referral systems and inaccessibility of rehabilitation centers [<xref ref-type="bibr" rid="scirp.132467-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref11">11</xref>] . Apart from urban areas, there has been little development of CR in sub-Saharan Africa [<xref ref-type="bibr" rid="scirp.132467-ref12">12</xref>] . For instance, in regions such as western Kenya, where the burden of HF is high, CR programs are nonexistent [<xref ref-type="bibr" rid="scirp.132467-ref3">3</xref>] . The same is true in Senegal, where there is only one public cardiac rehabilitation center located in the capital and established in 2015. To demonstrate its interest in the management of heart diseases, a prospective study was conducted with the aim of assessing the effects of physical rehabilitation on cardiac function in patients with heart diseases in Senegal.</p></sec><sec id="s2"><title>2. Material and Methods</title><p>The study was conducted at the cardiac rehabilitation unit of the cardiology department of the Dalal Jamm Hospital in Dakar and the Laboratory of Physiology and Functional Explorations of the FMPO of the Cheikh Anta Diop University of Dakar. It was a prospective descriptive and analytical study conducted over a period of five months from July 1 to November 31, 2021. The study population consisted of any consenting adult patient with a cardiac pathology indicated to participate in the cardiovascular rehabilitation program. Patients who stopped the program due to deterioration of their health or who abandoned the rehabilitation program for personal reasons were excluded. Sociodemographic and clinical data were collected from the study population. Patients were evaluated at the beginning and end of cardiovascular rehabilitation by cardiovascular parameters, including systolic and diastolic blood pressures (SBP, DBP), mean arterial pressure (MAP), and heart rate (HR); biological parameters (hemogram, renal and lipid balance, fasting glycemia, glycosylated hemoglobin); and echocardiographic parameters (dimension of cardiac cavities, wall kinetics, and systolic function of the ventricles).</p><p>The protocol of cardiac rehabilitation (CR) involved several steps: first, a comprehensive initial assessment to stratify the patient’s risk and adapt the modalities and monitoring of CR. This initial assessment included a clinical examination with a history and a complete physical examination, a biological assessment of cardiovascular risk factors, an electrocardiogram, a transthoracic echocardiography, and a triangular exercise test on a bicycle with an increase of 25 Watt per minute. This allowed to determine the level of retraining, the initial load, the heart rate (HR) at maximal effort (HRmax) and the HR of retraining (HRR) according to the Karvonen formula:</p><p>HRR = HRrest + K ( HRmax − HRrest ) ;</p><p>K = 0.6 if patient without beta-blocker and 0.8 if with beta-blocker [<xref ref-type="bibr" rid="scirp.132467-ref13">13</xref>] .</p><p>Then, the second step consisted of starting the CR sessions with 3 sessions per week after a warm-up of 5 to 10 minutes. Each retraining session had two phases with a prescribed load after risk and functional capacity assessment, first on a bike for 15 to 30 minutes then on a treadmill for 15 to 30 minutes, followed by a recovery phase of 3 to 5 minutes. The Borg scale was used during the retraining sessions to measure the perception of effort. The average number of CR sessions was 15 to 20 sessions.</p><p>Finally, the third step consisted of evaluating the effect of the cardiovascular rehabilitation program by conducting a post-rehabilitation assessment. A physical examination was performed with a measurement of cardiovascular parameters and a biological assessment. Additionally, cardiac function and functional capacity were evaluated respectively by echocardiographic assessment and a final exercise test to determine the theoretical maximum heart rate (MHR) achieved and the training heart rate (THR). Patients also received education sessions and advice on nutrition.</p><p>Data analysis was performed using Graph Prism version 5 software. Quantitative data were expressed as means +/− standard deviation. The T-Test was used to compare these quantitative data between the period before and after rehabilitation. As for qualitative variables, they were expressed as proportions and the Chi-square test was used to evaluate the impact of cardiovascular rehabilitation. The significance level was set at p &lt; 0.05.</p></sec><sec id="s3"><title>3. Results</title><p>Out of the 17 registered patients, 4 patients interrupted the rehabilitation, 1 patient had decompensation during the program, and 12 finished their session and benefited from their final assessments. They consisted of 67% men with a sex ratio of 2.04, and the average age was 63.08 &#177; 7.57 years (<xref ref-type="table" rid="table1">Table 1</xref>). The different risk factors found among the participants were mainly sedentary lifestyle (100%) and hypertension (83%), followed by diabetes and obesity (42%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Among the patients, 75% had coronary artery disease, 16% had hypertension, 8% had dilated cardiomyopathy (DCM) of unknown etiology, and 8% had obstructive sleep apnea syndrome (OSAS).</p><p>Regarding cardiovascular parameters, it was found that the mean hemodynamic constants were not significantly modified after cardiac rehabilitation. However, there was a significant improvement in the body mass index measured at the beginning and end of the rehabilitation protocol. Indeed, the mean BMI</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Characteristics of patients indicated for the cardiovascular rehabilitation (CR) program</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >PATIENT CHARACTERISTICS</th><th align="center" valign="middle" >VALUES</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >Number of registered participants</td><td align="center" valign="middle" >17</td></tr><tr><td align="center" valign="middle"  colspan="2"  >CR interruption</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Decompensation during CR</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Number of participants having finished CR</td><td align="center" valign="middle" >12</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Sex</td><td align="center" valign="middle" >67% Men/33% Women</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Average age</td><td align="center" valign="middle" >63.08 +/− 7.57 years</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >DiagnosiS</td><td align="center" valign="middle" >Coronary artery disease</td><td align="center" valign="middle" >75%</td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >16%</td></tr><tr><td align="center" valign="middle" >DCM</td><td align="center" valign="middle" >8%</td></tr><tr><td align="center" valign="middle" >OSAS</td><td align="center" valign="middle" >8%</td></tr></tbody></table></table-wrap><p>DCM: Dilated Cardiomyopathy; OSAS: Obstructive Sleep Apnea Syndrome.</p><p>decreased from 27.14 &#177; 3.28 to 25.1 &#177; 2.19 after physical training sessions (p = 0.004). There was no significant difference in the mean values of the hematogram elements before and after rehabilitation.</p><p>The renal assessment performed on patients before and after rehabilitation did not show a significant modification. However, between the beginning and the end of the rehabilitation, there was a significant decrease in the total cholesterol level, which decreased from 1.74 to 1.52 g/L (p &lt; 0.0001), the LDL-cholesterol level, which decreased from 1.09 g/L to 0.92 g/L (p = 0.0047), and the triglyceride level, which decreased from 1.10 g/L to 0.98 g/L (p = 0.0083). Moreover, the HDL-cholesterol level did not have a significant modification.</p><p>The glycemic assessment of patients after rehabilitation showed a significant difference. Indeed, the average fasting blood glucose level decreased from 1.25 &#177; 0.48 g/L to 0.92 &#177; 0.18 g/L (p = 0.0499), and the glycosylated hemoglobin level decreased from 7.72% &#177; 0.01% to 6.45% &#177; 0.008% (p = 0.0441) (<xref ref-type="table" rid="table2">Table 2</xref>).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Physical and biological parameters improved during cardiac rehabilitation</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Parameters studied</th><th align="center" valign="middle"  colspan="2"  >Cardiac rehabilitation</th><th align="center" valign="middle"  rowspan="2"  >p value</th></tr></thead><tr><td align="center" valign="middle" >Before</td><td align="center" valign="middle" >After</td></tr><tr><td align="center" valign="middle" >Cardiovascular parameters</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >SBP (mmHg)</td><td align="center" valign="middle" >131.3 &#177; 15.5</td><td align="center" valign="middle" >125 &#177; 9.5</td><td align="center" valign="middle" >0.2097</td></tr><tr><td align="center" valign="middle" >DBP (mmHg)</td><td align="center" valign="middle" >77.4 &#177; 7.25</td><td align="center" valign="middle" >77.5 &#177; 3.5</td><td align="center" valign="middle" >0.9789</td></tr><tr><td align="center" valign="middle" >MAP (mmHg)</td><td align="center" valign="middle" >95.4 &#177; 9.65</td><td align="center" valign="middle" >93.4 &#177; 4.5</td><td align="center" valign="middle" >0.5554</td></tr><tr><td align="center" valign="middle" >HR (bpm)</td><td align="center" valign="middle" >72.5 &#177; 9.65</td><td align="center" valign="middle" >70.6 &#177; 7.5</td><td align="center" valign="middle" >0.3851</td></tr><tr><td align="center" valign="middle" >Weight (kg)</td><td align="center" valign="middle" >78.25 &#177; 10.96</td><td align="center" valign="middle" >75.24 &#177; 10.95</td><td align="center" valign="middle" >0.004</td></tr><tr><td align="center" valign="middle" >BMI (kg/m<sup>2</sup>)</td><td align="center" valign="middle" >27.14 &#177; 3.28</td><td align="center" valign="middle" >25.1 &#177; 2.19</td><td align="center" valign="middle" >0.004</td></tr><tr><td align="center" valign="middle" >Hematological parameters</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hemoglobin (g/dL)</td><td align="center" valign="middle" >12.7 &#177; 1.03</td><td align="center" valign="middle" >12.6 &#177; 0.51</td><td align="center" valign="middle" >0.8349</td></tr><tr><td align="center" valign="middle" >Hematocrit (%)</td><td align="center" valign="middle" >47.8 &#177; 2.08</td><td align="center" valign="middle" >46.8 &#177; 1.38</td><td align="center" valign="middle" >0.1388</td></tr><tr><td align="center" valign="middle" >Red Blood Cells (elements/mm<sup>3</sup>)</td><td align="center" valign="middle" >5.63 &#177; 1.02</td><td align="center" valign="middle" >5.47 &#177; 0.96</td><td align="center" valign="middle" >0.9864</td></tr><tr><td align="center" valign="middle" >White Blood Cells (elements/mm<sup>3</sup>)</td><td align="center" valign="middle" >6.63 &#177; 1.02</td><td align="center" valign="middle" >6.56 &#177; 0.83</td><td align="center" valign="middle" >0.8031</td></tr><tr><td align="center" valign="middle" >Platelets (elements/mm<sup>3</sup>)</td><td align="center" valign="middle" >344.9 &#177; 81.5</td><td align="center" valign="middle" >388 &#177; 68.1</td><td align="center" valign="middle" >0.4884</td></tr><tr><td align="center" valign="middle" >Biochemical parameters</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Fasting blood sugar (g/L)</td><td align="center" valign="middle" >1.25 &#177; 0.48</td><td align="center" valign="middle" >0.92 &#177; 0.18</td><td align="center" valign="middle" >0.0499</td></tr><tr><td align="center" valign="middle" >HbA1c (%)</td><td align="center" valign="middle" >7.72 &#177; 0.01</td><td align="center" valign="middle" >6.45% &#177; 0.008</td><td align="center" valign="middle" >0.0441</td></tr><tr><td align="center" valign="middle" >Urea (g/L)</td><td align="center" valign="middle" >0.319 &#177; 0.06</td><td align="center" valign="middle" >0.325 &#177; 0.048</td><td align="center" valign="middle" >0.5344</td></tr><tr><td align="center" valign="middle" >Creatinemia (mg/L)</td><td align="center" valign="middle" >11.65 &#177; 3.43</td><td align="center" valign="middle" >10.81 &#177; 2.66</td><td align="center" valign="middle" >0.1745</td></tr><tr><td align="center" valign="middle" >Ch-T (g/L)</td><td align="center" valign="middle" >1.74</td><td align="center" valign="middle" >1.52</td><td align="center" valign="middle" >0.00098</td></tr><tr><td align="center" valign="middle" >LDL-C (g/L)</td><td align="center" valign="middle" >1.09</td><td align="center" valign="middle" >0.92</td><td align="center" valign="middle" >0.0047</td></tr><tr><td align="center" valign="middle" >HDL-C (g/L)</td><td align="center" valign="middle" >0.46</td><td align="center" valign="middle" >0.48</td><td align="center" valign="middle" >0.547</td></tr><tr><td align="center" valign="middle" >TG (g/L)</td><td align="center" valign="middle" >1.1</td><td align="center" valign="middle" >0.98</td><td align="center" valign="middle" >0.0083</td></tr></tbody></table></table-wrap><p>The echocardiographic parameters studied showed after the rehabilitation program, an improvement in the dilation of cardiac cavities in 8.33% of patients, normalization of the left ventricular ejection fraction (LVEF) in 16% of patients with moderately reduced LVEF at the beginning, improvement in kinetic disorders in 16% of patients, and recovery of right ventricular systolic function (RVSF) in all patients with RVSF alteration at the beginning. Thus, there was a significant improvement in systolic heart function, considering the mean LVEF which increased from 51% to 57% (p = 0.00588) (<xref ref-type="table" rid="table3">Table 3</xref>). A better physical ability of patients was observed after the rehabilitation program. Indeed, the mean functional capacity of the study population increased from 6.58 &#177; 3.2 to 8 &#177; 3.4 Mets (p = 1.96 &#215; 10<sup>−</sup>⁵). A significant improvement in cardiac reserve was observed at the end of the retraining protocol (74% vs 85%; p = 0.0011).</p></sec><sec id="s4"><title>4. Discussion</title><p>Our study showed that cardiovascular rehabilitation has beneficial effects in patients with heart disease. Our results are consistent with the literature. Indeed, the five main cardiovascular risk factors found in our population (sedentary lifestyle, hypertension, diabetes, obesity, and dyslipidemia) had been identified by the INTERHEART AFRICA study as responsible for 89.2% of the risk of myocardial infarction in the African population [<xref ref-type="bibr" rid="scirp.132467-ref13">13</xref>] . These same factors were found by Pavy et al. [<xref ref-type="bibr" rid="scirp.132467-ref14">14</xref>] . The mean age of our patients (63.08 &#177; 7.57 years) was comparable to that of the Moroccan study, which was 56.57 &#177; 10.2 years with a male predominance (87.5%). Similarly, coronary artery disease was the most frequent</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Cardiac morphological and hemodynamic parameters improved during cardiac rehabilitation</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Parameters</th><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >Cardiac rehabilitation</th><th align="center" valign="middle"  rowspan="2"  >P value</th></tr></thead><tr><td align="center" valign="middle" >Before</td><td align="center" valign="middle" >After</td></tr><tr><td align="center" valign="middle"  rowspan="4"  >Left Ventricular Ejection Fraction (LVEF)</td><td align="center" valign="middle" >Reduced</td><td align="center" valign="middle" >17%</td><td align="center" valign="middle" >9%</td><td align="center" valign="middle" >0.73</td></tr><tr><td align="center" valign="middle" >Moderately Reduced</td><td align="center" valign="middle" >25%</td><td align="center" valign="middle" >9%</td><td align="center" valign="middle" >0.043</td></tr><tr><td align="center" valign="middle" >Preserved</td><td align="center" valign="middle" >58%</td><td align="center" valign="middle" >84%</td><td align="center" valign="middle" >0.047</td></tr><tr><td align="center" valign="middle" >Average</td><td align="center" valign="middle" >51%</td><td align="center" valign="middle" >57%</td><td align="center" valign="middle" >0.89</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Kinetics of the walls of the Left Ventricle</td><td align="center" valign="middle" >Kinetic disorders</td><td align="center" valign="middle" >58%</td><td align="center" valign="middle" >42%</td><td align="center" valign="middle" >0.736</td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >42%</td><td align="center" valign="middle" >58%</td><td align="center" valign="middle" >0.85</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Systolic function of the right ventricle (RVSF)</td><td align="center" valign="middle" >Impaired</td><td align="center" valign="middle" >16%</td><td align="center" valign="middle" >0%</td><td align="center" valign="middle" >0.005</td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >84%</td><td align="center" valign="middle" >100%</td><td align="center" valign="middle" >0.96</td></tr><tr><td align="center" valign="middle" >Exercise Test Parameters</td><td align="center" valign="middle" >Average Functional Capacity (Watts)</td><td align="center" valign="middle" >99.08 &#177; 22.05</td><td align="center" valign="middle" >123.08 &#177; 22.07</td><td align="center" valign="middle" >1.96 &#215; 10<sup>−5</sup></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Theoretical Maximum Frequency reached</td><td align="center" valign="middle" >75%</td><td align="center" valign="middle" >85%</td><td align="center" valign="middle" >0.0011</td></tr></tbody></table></table-wrap><p>indication in this study (75%) [<xref ref-type="bibr" rid="scirp.132467-ref15">15</xref>] , as well as in the study by Kinic et al. (61.5%) [<xref ref-type="bibr" rid="scirp.132467-ref16">16</xref>] . In the EUROACTION study where patients were followed up for one year, participation in the rehabilitation program was also associated with better control of obesity and overweight [<xref ref-type="bibr" rid="scirp.132467-ref17">17</xref>] . Another study conducted in Johannesburg, South Africa, also reported a reduction in weight and skinfold thickness after 6 months in patients who complied well with the program [<xref ref-type="bibr" rid="scirp.132467-ref18">18</xref>] . Prolonged and regular endurance training facilitates weight loss, improves the distribution of perivisceral fat, and contributes to the reduction of abdominal circumference.</p><p>A similar improvement in lipid and glycemic profile during rehabilitation was also found by Pavy et al. and in the EUROACTION study [<xref ref-type="bibr" rid="scirp.132467-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref17">17</xref>] . It is known that aerobic and resistance physical exercise beyond a few weeks contributes to improving the lipid profile. Exercise retraining is associated with a decrease in LDL cholesterol and a modest increase in HDL cholesterol. Moreover, physical exercise leads to an improvement in insulin resistance index, reduces hyperinsulinemia and insulin requirements. In general, better glycemic control is observed with physical activity. Physical exercise in cardiac patients has a beneficial effect widely demonstrated in many studies [<xref ref-type="bibr" rid="scirp.132467-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref23">23</xref>] . They showed an improvement equivalent to treatment with beta-blockers [<xref ref-type="bibr" rid="scirp.132467-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref25">25</xref>] . As for cardiac systolic function, the studies by Mouine N. [<xref ref-type="bibr" rid="scirp.132467-ref15">15</xref>] and Rhissassi [<xref ref-type="bibr" rid="scirp.132467-ref26">26</xref>] , had reported a marked improvement in LVEF after a cardiovascular rehabilitation program. Indeed, rehabilitation allows, in the long term, to improve systolic function estimated by ejection fraction, ventricular filling parameters and diastolic function in general, and to reduce the effects of ventricular remodeling.</p><p>From a physical fitness perspective, our results were consistent with those of Rhissassi in his study, which found an average functional capacity of 6.58 &#177; 3.2 Mets at the initial evaluation and 8 &#177; 3.4 Mets at the end of a physical retraining program [<xref ref-type="bibr" rid="scirp.132467-ref26">26</xref>] . Manzoni et al. also found similar results in their population of coronary patients with a 30.3% improvement in physical fitness after the rehabilitation program (p &lt; 0.001) [<xref ref-type="bibr" rid="scirp.132467-ref27">27</xref>] . These data suggest that rehabilitation through exercise retraining would improve the patient’s functional capacity and functional prognosis. Indeed, the beneficial effects of exercise training occur at different levels, on the cardiocirculatory function, skeletal muscle performance, and respiratory function. They include blood and neurohormonal metabolic effects. The improvement of peripheral muscle function plays a major role. It results from an increase in blood perfusion, capillary density, improvement of oxidative enzymatic activity, and an increase in mitochondrial density. For the past twenty years, the vascular endothelium has emerged as a key element in the circulation of peripheral and coronary blood vessels [<xref ref-type="bibr" rid="scirp.132467-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.132467-ref30">30</xref>] . Indeed, endothelial dysfunction is considered the primum movens of various cardiovascular pathologies. It is present in both coronary and heart failure pathologies.</p><p>Regular physical exercise could cause an increase in shear forces, also called “shear stress”, which act on endothelial mechanoreceptors and would stimulate the production of endothelial NO synthase (e-NO synthase). This mechanohormonal transduction involves phosphorylation, acetylation, and coupling/uncoupling phenomena. This could lead to the local release of NO, which is considered the most powerful vasodilator in the body [<xref ref-type="bibr" rid="scirp.132467-ref28">28</xref>] . This increased release of NO would be responsible for improving circulation and allowing the cardiovascular system to increase its physiological functions such as systolic ejection or good diastolic filling. Regular physical activity could also lead to a reduction in the release of oxygen-derived free radicals (ROS: Reactive Oxygen Species). Moreover, the activation of e-NO synthase induced by physical training, in association with mobilization factors of vascular endothelial growth factors (VEGF) and metalloproteinases, is also involved in the processes of neovascularization and angiogenesis [<xref ref-type="bibr" rid="scirp.132467-ref28">28</xref>] . The production of neovessels in the body would improve physical fitness and reduce cardiovascular risk [<xref ref-type="bibr" rid="scirp.132467-ref20">20</xref>] . Authors have also reported that any gain in functional capacity of 1 Mets (3.5 ml/min/kg of oxygen) would be accompanied by a decrease in mortality of nearly 15% [<xref ref-type="bibr" rid="scirp.132467-ref11">11</xref>] .</p></sec><sec id="s5"><title>5. Study Limitations</title><p>Our study has some limitations that should be taken into account when interpreting the results. First, the cardiorespiratory exercise test based on the analysis of respiratory gas evolution was not performed in our patients due to the unavailability of the equipment. Second, markers such as eNO, ROS, VEGF, etc., were not evaluated, which could have provided additional insights into the physiological mechanisms underlying the observed effects. Finally, the study population was small, which may limit the generalizability of the findings to other populations. Despite these limitations, our study provides valuable information on the effects of cardiac rehabilitation on cardiovascular risk factors and functional capacity.</p></sec><sec id="s6"><title>6. Conclusion</title><p>In conclusion, the cardiac rehabilitation program has a beneficial effect on aerobic capacity, improves cardiovascular risk factors and quality of life, and reduces cardiovascular morbidity and mortality. Exercise retraining should be considered, by the cardiologist and the patient, as an integral and indispensable element of the overall treatment of heart diseases. Individuals who follow this program have improved physical parameters such as an increase in maximum workload and a reduction in associated cardiovascular risk factors. However, the prescription rate is still low in Senegal and generally in sub-Saharan Africa, due to several obstacles ranging from the low level of reference of doctors to inadequate social support and difficulties in following the rehabilitation program. Therefore, measures should be taken to promote cardiac rehabilitation in all sub-Saharan African countries in general and in Senegal in particular.</p></sec><sec id="s7"><title>Acknowledgements</title><p>We thank the international research laboratory, environment, society, and health (IRL3189-ESS CNRS-UCAD) which participated in the financing of this study.</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s9"><title>Cite this paper</title><p>Ba-Diop, A., Sow, A.K., Khaled, R.M., Diaw, M., Coly, M.S., Faye, F.A., Ndiad&#233;, A., Gaye, B., Ba, A. and Samb, A. (2024) Interest of Cardiac Rehabilitation in Patients with Heart Disease in a Cardiology Department in Senegal. World Journal of Cardiovascular Diseases, 14, 217-227. https://doi.org/10.4236/wjcd.2024.144017</p></sec></body><back><ref-list><title>References</title><ref id="scirp.132467-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Roth, G.A., Abate, D., Abate, K.H., Abay, S.M., Abbafati, C., Abbasi, N., &lt;i&gt;et al&lt;/i&gt;. (2018) Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. &lt;i&gt;The Lancet&lt;/i&gt;, 392, 1736-1788.</mixed-citation></ref><ref id="scirp.132467-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Heine, M., Turk-Adawi, K., Supervia, M., Derman, W., Lopez-Jimenez, F., Naidoo, P., &lt;i&gt;et al&lt;/i&gt;. (2019) Cardiac Rehabilitation Delivery in Africa. &lt;i&gt;Cardiovascular Journal of Africa&lt;/i&gt;, 30, 133-137. &lt;br&gt;https://doi.org/10.5830/CVJA-2019-011</mixed-citation></ref><ref id="scirp.132467-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Ngeno, G.T.K., Barasa, F., Kamano, J., Kwobah, E., Wambui, C., Binanay, C., &lt;i&gt;et al&lt;/i&gt;. (2022) Feasibility of Cardiac Rehabilitation Models in Kenya. &lt;i&gt;Annals of Global Health&lt;/i&gt;, 88, 7. &lt;br&gt;https://doi.org/10.5334/aogh.3392</mixed-citation></ref><ref id="scirp.132467-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Heine, M., Lupton-Smith, A., Pakosh, M., Grace, S.L., Derman, W. and Hanekom, S.D. (2019) Exercise-Based Rehabilitation for Major Non-Communicable Diseases in Low-Resource Settings: A Scoping Review. &lt;i&gt;BMJ Glob&lt;/i&gt;&lt;i&gt;al&lt;/i&gt;&lt;i&gt; Health&lt;/i&gt;, 4, Article e001833. &lt;br&gt;https://doi.org/10.1136/bmjgh-2019-001833</mixed-citation></ref><ref id="scirp.132467-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Affangla, D.A., Ba, F., Ba, D.M., Ndiaye, M., Mboup, W.N., Wabo, A.S., &lt;i&gt;et al&lt;/i&gt;. (2019) Epid&amp;#233;miologie et &amp;#233;tiologie de l&amp;#8217;insuffisance cardiaque chez l&amp;#8217;adulte au centre DIABCARMET de l&amp;#8217;h&amp;#244;pital Saint Jean de Dieu de Thi&amp;#232;s (S&amp;#233;n&amp;#233;gal). &lt;i&gt;Revue Africaine de&lt;/i&gt;&lt;i&gt; &lt;/i&gt;&lt;i&gt;M&amp;#233;decine Interne&lt;/i&gt;, 6, 29-37.</mixed-citation></ref><ref id="scirp.132467-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">WHO Expert Committee on Rehabilitation after Cardiovascular Diseases with Special Emphasis on Developing Countries. (2023) R&amp;#233;adaptation apr&amp;#232;s maladie cardio-vasculaire, eu &amp;#233;gard plus sp&amp;#233;cialement aux pays en d&amp;#233;veloppement: Rapport d&amp;#8217; un comit&amp;#233; OMS d&amp;#8217; experts. </mixed-citation></ref><ref id="scirp.132467-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Pesah, E., Turk-Adawi, K., Supervia, M., Lopez-Jimenez, F., Britto, R., Ding, R., &lt;i&gt;et al&lt;/i&gt;. (2019) Cardiac Rehabilitation Delivery in Low/Middle-Income Countries. &lt;i&gt;Heart&lt;/i&gt;, 105, 1806-1812. &lt;br&gt;https://doi.org/10.1136/heartjnl-2018-314486</mixed-citation></ref><ref id="scirp.132467-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Grace, S.L., Turk-Adawi, K.I., Contractor, A., Atrey, A., Campbell, N.R.C., Derman, W., &lt;i&gt;et al&lt;/i&gt;. (2016) Cardiac Rehabilitation Delivery Model for Low-Resource Settings: An International Council of Cardiovascular Prevention and Rehabilitation Consensus Statement. &lt;i&gt;Progress in Cardiovascular Diseases&lt;/i&gt;, 59, 303-322. &lt;br&gt;https://doi.org/10.1016/j.pcad.2016.08.004</mixed-citation></ref><ref id="scirp.132467-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Grace, S.L, Turk-Adawi, K., Contractor, A., Atrey, A., Campbell, N., Derman, W., &lt;i&gt;et al&lt;/i&gt;. (2016) Cardiac Rehabilitation Delivery Model for Low-Resource Settings. &lt;i&gt;Heart&lt;/i&gt;, 102, 1449-1455. &lt;br&gt;https://doi.org/10.1136/heartjnl-2015-309209</mixed-citation></ref><ref id="scirp.132467-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Karmali, K.N., Davies, P., Taylor, F., Beswick, A., Martin, N. and Ebrahim, S. (2014) Promoting Patient Uptake and Adherence in Cardiac Rehabilitation. &lt;i&gt;Cochrane D&lt;/i&gt;&lt;i&gt;a&lt;/i&gt;&lt;i&gt;tabase of Systematic Reviews&lt;/i&gt;, No. 6, Article No. CD007131. &lt;br&gt;https://doi.org/10.1002/14651858.CD007131.pub3</mixed-citation></ref><ref id="scirp.132467-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Adghar, D., Bougherbal, R., Hanifi, R. and Khellaf, N. (2008) La r&amp;#233;adaptation cardiaque du coronarien: Premi&amp;#232;re exp&amp;#233;rience en Alg&amp;#233;rie. &lt;i&gt;Annales de Cardiologie et d&lt;/i&gt;&amp;#8217;&lt;i&gt;Ang&amp;#233;iologie&lt;/i&gt;, 57, 44-47. &lt;br&gt;https://doi.org/10.1016/j.ancard.2007.11.001</mixed-citation></ref><ref id="scirp.132467-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Binanay, C.A., Akwanalo, C.O., Aruasa, W., Barasa, F.A., Corey, G.R., Crowe, S., &lt;i&gt;et al&lt;/i&gt;. (2015) Building Sustainable Capacity for Cardiovascular Care at a Public Hospital in Western Kenya. &lt;i&gt;Journal of the American College of Cardiology&lt;/i&gt;, 66, 2550-2560. &lt;br&gt;https://doi.org/10.1016/j.jacc.2015.09.086</mixed-citation></ref><ref id="scirp.132467-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Steyn, K., Sliwa, K., Hawken, S., Commerford, P., Onen, C., Damasceno, A., &lt;i&gt;et al&lt;/i&gt;.&lt;i&gt; &lt;/i&gt;(2005) Risk Factors Associated with Myocardial Infarction in Africa. &lt;i&gt;Circulation&lt;/i&gt;, 112, 3554-3561. &lt;br&gt;https://doi.org/10.1161/CIRCULATIONAHA.105.563452</mixed-citation></ref><ref id="scirp.132467-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Pavy, B., Tisseau, A. and Caillon, M. (2011) Le patient coronarien six mois apr&amp;#232;s la r&amp;#233;adaptation cardiaque: Recherche sur l&amp;#8217;&amp;#233;valuation de la r&amp;#233;adaptation (&amp;#233;tude RER). &lt;i&gt;Annales de Cardiologie et d&lt;/i&gt;&amp;#8217;&lt;i&gt;Ang&amp;#233;iologie&lt;/i&gt;, 60, 252-258. &lt;br&gt;https://doi.org/10.1016/j.ancard.2011.08.004</mixed-citation></ref><ref id="scirp.132467-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Mouine., N. and Berrada, N.E. (2023) La r&amp;#233;adaptation cardiaque: L&amp;#8217;exp&amp;#233;rience du premier centre marocain. &lt;i&gt;Revue Marocaine de Cardiologie&lt;/i&gt;, No. 28, 4-9.&lt;br&gt;https://smcmaroc.org/wp-content/uploads/2020/08/RMC_N_28.pdf</mixed-citation></ref><ref id="scirp.132467-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Kinic, B. (2023) La r&amp;#233;adaptation cardiaque chez les sujets &amp;#226;g&amp;#233;s: &amp;#233;tude r&amp;#233;trospective d&amp;#8217;une s&amp;#233;rie de 200 patients &amp;#226;g&amp;#233;s de 75 &amp;#224; 91 ans.&lt;br&gt;https://www.semanticscholar.org/paper/La-réadaptation-cardiaque-chez-les-sujets-agés:-de-Kinic/317b9c553e215011a27c5cc83ec49e5c335e6346</mixed-citation></ref><ref id="scirp.132467-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Wood, D.A., Kotseva, K., Connolly, S., Jennings, C., Mead, A., Jones, J., &lt;i&gt;et al&lt;/i&gt;. (2008) Nurse-Coordinated Multidisciplinary, Family-Based Cardiovascular Disease Prevention Programme (EUROACTION) for Patients with Coronary Heart Disease and Asymptomatic Individuals at High Risk of Cardiovascular Disease: A Paired, Cluster-Randomised Controlled Trial. &lt;i&gt;The &lt;/i&gt;&lt;i&gt;Lancet&lt;/i&gt;, 371, 1999-2012. &lt;br&gt;https://doi.org/10.1016/S0140-6736(08)60868-5</mixed-citation></ref><ref id="scirp.132467-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Digenio, A.G., Padayachee, N. and Groeneveld, H. (1992) Multivariate Models for Compliance with Phase 3 Cardiac Rehabilitation Services in Johannesburg. &lt;i&gt;Annals of the &lt;/i&gt;&lt;i&gt;Academy of Medicine of&lt;/i&gt;&lt;i&gt; &lt;/i&gt;&lt;i&gt;Singapore&lt;/i&gt;, 21, 121-127.</mixed-citation></ref><ref id="scirp.132467-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Sampson, L. (2014) A Multidisciplinary Approach to Cardiac Rehabilitation in SA. &lt;i&gt;South African Medical Journal&lt;/i&gt;=&lt;i&gt;Suid&lt;/i&gt;-&lt;i&gt;Afrikaanse Tydskrif Vir Geneeskunde&lt;/i&gt;, 104, 94.</mixed-citation></ref><ref id="scirp.132467-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Bozkurt, B., Fonarow, G.C., Goldberg, L.R., Guglin, M., Josephson, R.A., Forman, D.E., &lt;i&gt;et al&lt;/i&gt;. (2021) Cardiac Rehabilitation for Patients with Heart Failure: &lt;i&gt;JACC&lt;/i&gt; Expert Panel. &lt;i&gt;Journal of the American College of Cardiology&lt;/i&gt;, 77, 1454-1469. &lt;br&gt;https://doi.org/10.1016/j.jacc.2021.01.030</mixed-citation></ref><ref id="scirp.132467-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Namanja, A., Usman, A. and Odunuga, T. (2021) Effects of Cardiac Rehabilitation Treatment Modalities in Sub-Saharan Africa: A Systematic Review. &lt;i&gt;Malawi Medical Journal&lt;/i&gt;, 33, 287-296. &lt;br&gt;https://doi.org/10.4314/mmj.v33i4.10</mixed-citation></ref><ref id="scirp.132467-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Taylor, R.S., Long, L., Mordi, I.R., Madsen, M.T., Davies, E.J., Dalal, H., &lt;i&gt;et al&lt;/i&gt;. (2019) Exercise-Based Rehabilitation for Heart Failure: Cochrane Systematic Review, Meta-Analysis, and Trial Sequential Analysis.&lt;i&gt; &lt;/i&gt;&lt;i&gt;JACC&lt;/i&gt;:&lt;i&gt; &lt;/i&gt;&lt;i&gt;Heart Fail&lt;/i&gt;&lt;i&gt;ure&lt;/i&gt;, 7, 691-705. &lt;br&gt;https://doi.org/10.1016/j.jchf.2019.04.023</mixed-citation></ref><ref id="scirp.132467-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Lecourtois-Lavigne, P. (2002) L&amp;#8217;int&amp;#233;r&amp;#234;t de la r&amp;#233;&amp;#233;ducation cardiaque dans l&amp;#8217;insuffisance cardiaque chronique systolique: &amp;#224; propos de 58 patients. Ph. D. Thesis, Universit&amp;#233; Henri Poincar&amp;#233;, Nancy.</mixed-citation></ref><ref id="scirp.132467-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">McMahon, S.R., Ades, P.A. and Thompson, P.D. (2017) The Role of Cardiac Rehabilitation in Patients with Heart Disease. &lt;i&gt;Trends in Cardiovascular Medicine&lt;/i&gt;, 27, 420-425. &lt;br&gt;https://doi.org/10.1016/j.tcm.2017.02.005</mixed-citation></ref><ref id="scirp.132467-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Selim, G. (2013) Cardiac Rehabilitation in Egypt. &lt;i&gt;The &lt;/i&gt;&lt;i&gt;Lancet Glob&lt;/i&gt;&lt;i&gt;al&lt;/i&gt;&lt;i&gt; Health&lt;/i&gt;, 1, E72.&lt;br&gt;https://doi.org/10.1016/S2214-109X(13)70018-4</mixed-citation></ref><ref id="scirp.132467-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Rhissassi, A. (2023) R&amp;#233;adaptation cardiaque: Bilan d&amp;#8217;activit&amp;#233; &amp;#224; 8 mois de la premi&amp;#232;re exp&amp;#233;rience s&amp;#233;n&amp;#233;galaise. Ph.D. Thesis, Universit&amp;#233; Cheikh-Anta-Diop de Dakar, Dakar. </mixed-citation></ref><ref id="scirp.132467-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Manzoni, G.M., Villa, V., Compare, A., Castelnuovo, G., Nibbio, F., Titon, A.M., &lt;i&gt;et &lt;/i&gt;&lt;i&gt;al&lt;/i&gt;. (2011) Short-Term Effects of a Multi-Disciplinary Cardiac Rehabilitation Pro-gramme on Psychological Well-Being, Exercise Capacity and Weight in a Sample of Obese In-Patients with Coronary Heart Disease: A Practice-Level Study. &lt;i&gt;Psychology&lt;/i&gt;,&lt;i&gt; Health &amp; Medicine&lt;/i&gt;, 16, 178-189. &lt;br&gt;https://doi.org/10.1080/13548506.2010.542167</mixed-citation></ref><ref id="scirp.132467-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Bounhoure, J.P. and Bousquet, M. (2014) La r&amp;#233;adaptation cardiaque: Bases physio-logiques, effets b&amp;#233;n&amp;#233;fiques, contre-indications. &lt;i&gt;Bulletin de l&lt;/i&gt;&amp;#8217;&lt;i&gt;Acad&amp;#233;mie Nationale de M&amp;#233;decine&lt;/i&gt;, 198, 491-499. &lt;br&gt;https://doi.org/10.1016/S0001-4079(19)31317-2</mixed-citation></ref><ref id="scirp.132467-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Ghannem, M. (2010) La r&amp;#233;adaptation cardiaque en post-infarctus du myocarde. &lt;i&gt;Annales de Cardiologie et d&lt;/i&gt;&amp;#8217;&lt;i&gt;Ang&amp;#233;iologie&lt;/i&gt;, 59, 367-379. &lt;br&gt;https://doi.org/10.1016/j.ancard.2010.10.001</mixed-citation></ref><ref id="scirp.132467-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Puymirat, E., Bonaca, M., Iliou, M.C., Tea, V., Ducrocq, G., Douard, H., &lt;i&gt;et al&lt;/i&gt;. (2019) Outcome Associated with Prescription of Cardiac Rehabilitation according to Predicted Risk after Acute Myocardial Infarction: Insights from the FAST-MI Registries. &lt;i&gt;Archives of Cardiovascular Diseases&lt;/i&gt;, 112, 459-468.&lt;br&gt;https://doi.org/10.1016/j.acvd.2019.04.002</mixed-citation></ref></ref-list></back></article>